No abstract available.
Humans

No abstract available.
Drug Therapy* ; Erectile Dysfunction* ; Male

No abstract available.

No abstract available.
Periodicals*

No abstract available.
Health Policy*

No abstract available.
Fees, Medical* ; Korea*

PURPOSE: To evaluate the relibility of transrectal ultrasonography (TRUS) to define adult female genital organ and to diagnose and stage the cervical carcinomas. METHODS AND MATERIALS: After analysis of normal ultrasonographic anatomy of female pelvis in ten healthy women, I performed TRUS in thirty patients of uterine cervical carcinomas by rotating the 5 MHz electronic linear array transducer(SL2, Siemens, Erlangen, Germany) along the reference sagittal plane in the middle of uterine cervix & vagina. The results of TRUS were analyzed and compared to FIGO, surgical pathology, CT and MRT, ect. RESULTS: TRUS allowed good visualization of the uterus, uterine cervix, parametrium, vagina, anterior rectal wall, walls of the urinary bladder, and uterine cervical carcinomas. The accuracy of staging with TRUS was 83%, compared with the accuracy of 67% for clinical staging according to the criteria of the International Federation of Gynecotogy and Obstetrics(FIGO). For extent of parametrial involvement, the sensitivity of TRUS was 93%, with the specificity of 86% and the diagnostic accuracy of 89%. The same reliability parameters for clinical evaluation were 71%, 79%, and 75% respectively. CONCLUSION: Above findings suggest that low-cost TRUS could be usefully applied to pretreatment evaluation of patients with uterine cervical carcinoma.
Adult ; Cervix Uteri ; Diagnosis* ; Female ; Genitalia ; Humans ; Pathology, Surgical ; Pelvis ; Sensitivity and Specificity ; Ultrasonography* ; Urinary Bladder ; Uterus ; Vagina

Seventy five cases of urogenital malignant tumors were reviewed in regard to the survival, therapy and peripheral lymphocyte counts. Cellular immunity was also investigated in 15 cases of them by assessing their cutaneous delayed hypersensitivity responses to dinitrochlorobenzene (DNCB), compared with controls. I. The incidence of lymphopenia in the urogenital malignant tumors (20. 6%) was higher than that in the control group(10.0%). Most cases with lymphopenia showed poor survival, and data suggested that peripheral lymphocyte count was a useful parameter to estimate the prognosis of the urogenital malignant tumors. 2. Surgical treatments caused a temporal decrease of circulating lymphocyte counts by 27.6% which recovered to normal value within 4 weeks, and high dosage radiation therapy brought about persistent and higher degree of decrease of peripheral lymphocyte by 47.9% which persisted for up 1-2 years. 3. Cancer patients had a lower incidence of positive reaction (73.3% vs. 93.4% in controls) in investigation of cellular immune responses using quantitative DNCB contact sensitization. There may be a significant relationship between tumor stage and reactivity to DNCB in bladder cancers.
Dinitrochlorobenzene ; Humans ; Hypersensitivity, Delayed ; Immunity, Cellular ; Incidence ; Lymphocyte Count* ; Lymphocytes* ; Lymphopenia ; Prognosis ; Reference Values ; Urinary Bladder Neoplasms

No abstract available.

No abstract available.